- Outcomes and Use of Therapeutic Drug Monitoring in Multidrug-Resistant Tuberculosis Patients Treated in Virginia, 2009-2014
-
Heysell SK, Moore JL, Peloquin C, Ashkin D, Houpt ER
- KMID: 2320598
- Tuberc Respir Dis.
- 2015 Apr;78(2):78-84.
- doi: 10.4046/trd.2015.78.2.78
BACKGROUND: Reports of therapeutic drug monitoring (TDM) for second-line medications to treat multidrug-resistant tuberculosis (MDR-TB) remain limited. METHODS: A retrospective cohort from the Virginia state tuberculosis (TB) registry, 2009-2014, was analyzed... -
- CITED
-
- Close
- SHARE
-
- Close
- An Analysis of Antituberculosis Drug Susceptibility Test Results in Kyung Hee Medical Center During Recent Four years
-
Kim JH, Suh JT, Kim MH, Kim GY, Her SR, Lee HJ, Lee WI, Kang SY
- KMID: 1892735
- Korean J Clin Microbiol.
- 2004 Sep;7(2):182-185.
BACKGROUND: Tuberculosis is still one of the most seriously threatening infections in Korea, because of multidrug resistant tuberculosis. Results of antituberculosis drug susceptibility test can provide clinicians very important informations... -
- CITED
-
- Close
- SHARE
-
- Close
